InvestorsHub Logo
Followers 165
Posts 3153
Boards Moderated 0
Alias Born 11/03/2014

Re: brooktrail1933 post# 261627

Monday, 01/27/2020 3:24:21 PM

Monday, January 27, 2020 3:24:21 PM

Post# of 720852
There are a couple of points that go against what you posted:

1. Prins is not the Principal Investigator (PI), the PI is Timothy Cloughesy for this clinical trial.

2. The press release from UCLA & Phase One Foundation specifically mentions that the personalized dendritic cell vaccine was developed by Dr. Linda Liau, not Robert Prins. Here is the link:

https://cancer.ucla.edu/Home/Components/News/News/1370

3. If you click on this embedded link, "was developed by Liau at UCLA", in the article linked above, you will see that this personalized dendritic cell vaccine is identified as "DCVax". That embedded link is below:

http://newsroom.ucla.edu/releases/personalized-vaccine-increase-long-term-survival-glioblastoma

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News